Page last updated: 2024-10-20

trimethylamine and Atrial Fibrillation

trimethylamine has been researched along with Atrial Fibrillation in 3 studies

Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Melnychuk, I1
Lizogub, VG1
Zuo, K1
Liu, X1
Wang, P1
Jiao, J1
Han, C1
Liu, Z1
Yin, X1
Li, J1
Yang, X1
Chelu, MG1
Li, N1

Other Studies

3 other studies available for trimethylamine and Atrial Fibrillation

ArticleYear
GUT MICROBIOTA COMPOSITION AND ITS METABOLITES CHANGES IN PATIENTS WITH ATHEROSCLEROSIS AND ATRIAL FIBRILLATION.
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2022, Volume: 75, Issue:12

    Topics: Atherosclerosis; Atrial Fibrillation; Bacteria; Gastrointestinal Microbiome; Humans

2022
Metagenomic data-mining reveals enrichment of trimethylamine-N-oxide synthesis in gut microbiome in atrial fibrillation patients.
    BMC genomics, 2020, Jul-30, Volume: 21, Issue:1

    Topics: Atrial Fibrillation; Data Mining; Gastrointestinal Microbiome; Humans; Methylamines; Oxides

2020
Biomarkers (plasma trimethylamine-N-oxide) to predict atrial fibrillation: Are we there yet?
    International journal of cardiology, 2018, 09-15, Volume: 267

    Topics: Atrial Fibrillation; Biomarkers; Humans; Methylamines; Oxides

2018